Taking tiny, frequent amounts of the psychedelic drug lysergic acid diethylamide (LSD) might temporarily elevate mood for ...

Beacon is investigating the gene therapy in other pivotal trials, including the VISTA trial that is expected to readout in H2 2026.

Henderson, NV - May 08, 2026 - PRESSADVANTAGE - Las Vegas Eye Institute, a LASIK surgeon in Las Vegas, Nevada, has ...

Artiva Biotherapeutics (ARTV) is maintained as a "Buy," driven by FDA alignment for a single phase 3 trial of AlloNK plus ...

Profound Medical (NASDAQ:PROF) reported sharply higher first-quarter revenue and reiterated its view that adoption of its ...

According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...

Preliminary findings were presented at the 2025 ASCO Genitourinary Cancers Symposium. 2 Investigators reported that 71% of ...

EverythingALS has launched a new online tool called SAVA AI that uses artificial intelligence to instantly match people with amyotrophic lateral sclerosis (ALS) to clinical trials.

Objectives To identify whether patients with arrhythmia, heart failure or ischaemic heart disease presenting with anxiety ...

ReMEDy1 Data Informing Current Stroke Trial -- In moderate stroke patients (NIHSS 5-15), a 19% absolute functional outcome ...

Cord for Life® completes Phase 1 dosing for its FDA-authorized clinical trial using cord blood to treat lower back pain ...

The oral presentation, titled, “¹⁸⁶Rhenium-Nanoliposomes (¹⁸⁶RNL) for the Treatment of Leptomeningeal Metastases: Translational Insights from Clinical and Preclinical Models,” was delivered by ...